Short-Term Percutaneous Mechanical Circulatory Support in Acute Coronary Syndrome with Cardiogenic Shock: Which Device to Choose?
Journal of Cardiovascular Development and Disease · 18.02.2026 · 13 (2) · 99
DOI: 10.3390/jcdd13020099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 18.02.2026. Verfasst von Nardi Tetaj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, Campus Bio-Medico University Hospital, Via Alvaro del Portillo 200, 00128 Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiogenic shock (CS) remains a life-threatening syndrome characterized by reduced cardiac output and end-organ hypoperfusion, most commonly resulting from acute myocardial infarction (AMI). Despite advances in early revascularization and increasing use of percutaneous mechanical circulatory support (MCS), short-term mortality in AMI-related CS (AMI-CS) remains high. This review summarizes the contemporary evidence on short-term percutaneous MCS in AMI-CS, with a focus on intra-aortic balloon pump (IABP), Impella microaxial flow pumps, and venoarterial extracorporeal membrane oxygenation (VA-ECMO), and provides insights into device selection and implementation in clinical practice. We performed a comprehensive analysis of the most relevant randomized controlled trials and key guideline recommendations from European and North American societies concerning the use of MCS. Despite its long-standing, IABP has not demonstrated a mortality benefit in contemporary trials and is no longer recommended for routine use in AMI-CS without mechanical complications. Nevertheless, it remains widely used due to its simplicity, safety profile, and broad availability. In contrast, Impella devices provide active left ventricular unloading and have shown promising hemodynamic effects, with the DanGer Shock trial suggesting a potential survival benefit in carefully selected patients, at the expense of higher complication rates. VA-ECMO offers full cardiopulmonary support but is associated with the highest complication rates and increases left ventricular afterload, often requiring adjunctive unloading with devices such as Impella (ECPELLA). However, recent randomized trials have not demonstrated a clear survival advantage for VA-ECMO, and concerns regarding its complications persist. In conclusion, CS continues to pose major therapeutic challenges, and no single MCS device has consistently shown a survival benefit across all AMI-CS patient populations. Individualized, phenotype-driven strategies that incorporate hemodynamic profiling and timely escalation of support are essential. Further randomized studies are urgently needed to define optimal device selection, the timing of placement, and appropriate patient selection criteria. Institutional protocols guided by clinical stage, etiology, and available expertise will be pivotal in improving outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Unit, Campus Bio-Medico University Hospital, Via Alvaro del Portillo 200, 00128 Rome, Italy.
- Research Unit of Cardiovascular Science, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy.
- Division of Cardiology, Cardio-Thoracic and Vascular Department, San Camillo Forlanini Hospital, 00152 Rome, Italy.
ORCID-Profile: Nardi Tetaj, Domenico Gabrielli, Gian Paolo Ussia
Zitieren
APA
Tetaj, N., Nusca, A., Piccirillo, F., Halasz, G., Gabrielli, D., Ussia, G. P., & Grigioni, F. (2026). Short-Term Percutaneous Mechanical Circulatory Support in Acute Coronary Syndrome with Cardiogenic Shock: Which Device to Choose?. Journal of Cardiovascular Development and Disease, 13(2), 99. https://doi.org/10.3390/jcdd13020099
Vancouver
Tetaj N, Nusca A, Piccirillo F, Halasz G, Gabrielli D, Ussia GP, et al. Short-Term Percutaneous Mechanical Circulatory Support in Acute Coronary Syndrome with Cardiogenic Shock: Which Device to Choose?. Journal of Cardiovascular Development and Disease. 2026;13(2):99. doi:10.3390/jcdd13020099
BibTeX
@article{Tetaj2026,
author = {Tetaj, Nardi and Nusca, Annunziata and Piccirillo, Francesco and Halasz, Geza and Gabrielli, Domenico and Ussia, Gian Paolo and Grigioni, Francesco},
title = {Short-Term Percutaneous Mechanical Circulatory Support in Acute Coronary Syndrome with Cardiogenic Shock: Which Device to Choose?},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {2},
pages = {99},
doi = {10.3390/jcdd13020099}
}
EUVIMED